A mechanistic model of erythroblast growth inhibition providing a framework for optimisation of cell therapy manufacturing
- Submitting institution
-
Loughborough University
- Unit of assessment
- 12 - Engineering
- Output identifier
- 2200
- Type
- D - Journal article
- DOI
-
10.1016/j.bej.2018.01.033
- Title of journal
- Biochemical Engineering Journal
- Article number
- -
- First page
- 28
- Volume
- 133
- Issue
- -
- ISSN
- 1369-703X
- Open access status
- Compliant
- Month of publication
- January
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
3
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- This paper provided the basis for a fully funded collaboration with Advanced Bioprocess Services and their Boston, US based clients to test high efficiency manufacturing approaches to red blood cell production, including a consulting role for the academic team with a $B pharmaceutical start up (confidential agreement). It further provided the basis for the successful application for 500k of EPSRC Manufacturing the future funding and a research collaboration with US DoD and has been submitted as evidence for investor due diligence for a successful seed funding raised for New Biotech Safi Biosolutions.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
